News

Global Aids Update report titled, ’Aids, Crisis and the Power to Transform’, emphasises the urgent need for countries to ...
Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...
Known as the President's Emergency Plan for Aids Relief (Pepfar), it led to the investment of more than $100bn (£74bn) in the ...
Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care   The Big Story Global HIV program a ...
Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...
Thailand has reported over 13,000 new HIV cases so far this year, with infections surging among young people as condom use ...
Only 17,000 Ugandans to benefit from $1.1m Global Fund support as officials warn of high demand for long-acting prevention ...
South Africa might be cushioned from the global fallout in reduced funding for HIV prevention and treatment, but it has not been spared the effects, a global health report has found.
Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...